Ftse Mib
38.456,17
0,09%
DAX
22.425,93
0,73%
S&P 500
6.018,24
0,08%
NASDAQ
19.479,43
-0,23%
Bitcoin
94.283,59
-2,07%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX NovaBay Pharmaceuticals Inc New (NBY) NovaBay Pharmaceuticals Inc New (NBY) Notizie

NovaBay Pharmaceuticals Inc New

NBY
0,625
-0,005 (-0,79%)
Ultimo aggiornamento: 19:37:19
Dati in Delay di 15 minuti
Borsa: AMEX
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/2/202523:25EDGAR2Form PRE 14A - Other preliminary proxy statements
07/2/202500:30EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
04/2/202522:58EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
04/2/202522:58EDGAR2Form 8-K - Current report
23/1/202514:13EDGAR2Form 8-K - Current report
23/1/202514:12EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/1/202514:00BWNovaBay Pharmaceuticals Completes the Sale of its Eyecare..
22/1/202522:27EDGAR2Form 8-K - Current report
10/1/202513:03EDGAR2Form 8-K - Current report
19/12/202413:00EDGAR2Form 8-K - Current report
19/12/202412:50BWNovaBay Pharmaceuticals Announces the Further Adjournment of..
11/12/202422:12EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
09/12/202413:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
09/12/202412:50BWNovaBay CEO Letter to Stockholders Urges a FOR Vote at..
26/11/202422:08EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/11/202422:27EDGAR2Form 8-K - Current report
22/11/202422:05BWNovaBay Pharmaceuticals to Reconvene Special Meeting of..
15/11/202414:10EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
15/11/202414:00BWProminent Independent Proxy Advisory Firm ISS Supports..
13/11/202423:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/11/202422:52EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/11/202412:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/11/202423:31EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
07/11/202422:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202422:05BWNovaBay Pharmaceuticals Reports Third Quarter 2024 Financial..
06/11/202422:58EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/11/202422:46EDGAR2Form 8-K - Current report
06/11/202422:05BWNovaBay Pharmaceuticals Accepts Revised Offer from PRN..
29/10/202413:19EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/10/202413:15EDGAR2Form 8-K - Current report
29/10/202413:00BWNovaBay Pharmaceuticals Board Determines Unsolicited Offer..
16/10/202422:27EDGAR2Form 8-K - Current report
16/10/202422:19EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
25/9/202423:17EDGAR2Form PREM14A - Preliminary proxy statements relating to..
23/9/202415:27PRNUSKuehn Law Encourages COFS, ARC, RFL, and NBY Investors to..
20/9/202414:30PRNUSAcumen Health Holdings ("Acumen") to Acquire the Avenova..
20/9/202414:08EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
20/9/202414:08EDGAR2Form 8-K - Current report
20/9/202414:00BWNovaBay Pharmaceuticals Signs Definitive Agreement to Sell..
13/8/202422:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202422:05BWNovaBay Pharmaceuticals Reports Second Quarter 2024..
01/8/202412:50BWNovaBay Pharmaceuticals to Hold Second Quarter 2024..
30/7/202412:50BWNovaBay Pharmaceuticals Reports Record Amazon Prime Day..
29/7/202422:25EDGAR2Form 8-K - Current report
29/7/202422:05BWNovaBay Pharmaceuticals Announces Closing of $3.87 Million..
26/7/202423:19EDGAR2Form POS EX - Post-effective amendment adding exhibits to..
26/7/202414:30BWNovaBay Pharmaceuticals Announces Pricing of $3.5 Million..
16/7/202412:50BWNovaBay Pharmaceuticals Offers 20% Discounts on Avenova..
11/7/202414:50EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
11/7/202414:45EDGAR2Form 8-K - Current report
Apertura: 0,64 Min: 0,61 Max: 0,64
Chiusura: 0,63

La tua Cronologia

AMEX
NBY
NovaBay Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci